MindMed

Biotech

MindMed (NADSAQ: MNMD) Down 15% on FDA Development

MindMed, a company specializing in psychedelic medicine, experienced a significant drop in its stock price, falling 15% following news regarding…

Read More »
Stocks

This Company Was Just Granted a Health Canada Dealer’s License to Possess, Produce, Sell and Distribute Legal Cocaine

The new safe supply narcotics sector is evolving rapidly, but from an investment standpoint, it is in its infancy. One…

Read More »
Back to top button